NasdaqGM - Delayed Quote USD
Fulcrum Therapeutics, Inc. (FULC)
3.5100
-0.0800
(-2.23%)
At close: 4:00:01 PM EDT
3.5100
0.00
(0.00%)
After hours: 4:05:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-2,218
-2,218
-90,965
-97,050
-78,478
Investing Cash Flow
32,230
32,230
-36,692
12,413
-129,669
Financing Cash Flow
2,746
2,746
118,122
84,323
186,507
End Cash Position
59,413
59,413
26,655
36,190
36,504
Capital Expenditure
-278
-278
-508
-1,963
-1,713
Issuance of Capital Stock
--
--
117,345
80,804
182,857
Repayment of Debt
--
--
--
--
-18
Free Cash Flow
-2,496
-2,496
-91,473
-99,013
-80,191
12/31/2021 - 7/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGEM Cullinan Therapeutics, Inc.
8.14
-2.86%
RAPT RAPT Therapeutics, Inc.
0.8744
+1.13%
APGE Apogee Therapeutics, Inc.
37.05
+1.42%
TRVI Trevi Therapeutics, Inc.
6.35
+1.28%
IDYA IDEAYA Biosciences, Inc.
19.07
+1.33%
EWTX Edgewise Therapeutics, Inc.
15.40
+3.84%
SWTX SpringWorks Therapeutics, Inc.
44.93
+9.03%
DYN Dyne Therapeutics, Inc.
11.11
+3.06%
SRRK Scholar Rock Holding Corporation
34.38
+5.72%
SION Sionna Therapeutics, Inc.
12.60
-3.74%